Products Categories
CAS No.: | 59338-93-1 |
---|---|
Name: | Alizapride |
Molecular Structure: | |
Formula: | C16H21N5O2 |
Molecular Weight: | 315.375 |
Synonyms: | 1H-Benzotriazole-5-carboxamide,6-methoxy-N-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]- (9CI);Alizapride;N-(1-Allyl-2-pyrrolidinylmethyl)-6-methoxy-1H-benzotriazole-5-carboxamide; |
EINECS: | 261-710-6 |
Density: | 1.224 g/cm3 |
Melting Point: | 3360°C |
Boiling Point: | 580.3 °C at 760 mmHg |
Flash Point: | 304.8 °C |
Appearance: | COA |
PSA: | 83.14000 |
LogP: | 1.67550 |
alizapride
N-<(1-allyl-2-pyrrolidinyl)methyl>-6-hydroxy-1H-benzotriazole-5-carboxamide
Conditions | Yield |
---|---|
With sodium hydride; ethanethiol In N,N-dimethyl-formamide at 100 - 105℃; for 1.5h; | 46% |
alizapride
6-methoxy-1H-benzotriazole-5-carboxylic acid
Conditions | Yield |
---|---|
With hydrogenchloride In water at 80℃; Thermodynamic data; Kinetics; Rate constant; hydrolysis constants by the action of 1M NaOH(aq.), t0.5, other temperatures, ΔG(excit.); |
alizapride
N-<(1-allyl-2-pyrrolodinyl)methyl>-6-(1-methyl-2-oxopropoxy)-1H-benzotriazole-5-carboxamide
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 46 percent / sodium hydride, ethanethiol / dimethylformamide / 1.5 h / 100 - 105 °C 2: 2.) K2CO3, NaI / 1.) DMF, 3 h, 2.) room temperature, 16 h 3: 19 percent / aq. HCl / methanol / 0.17 h / 60 °C View Scheme |
alizapride
5-[(1-Allyl-pyrrolidin-2-ylmethyl)-carbamoyl]-6-(1-methyl-2-oxo-propoxy)-benzotriazole-1-carboxylic acid tert-butyl ester
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 46 percent / sodium hydride, ethanethiol / dimethylformamide / 1.5 h / 100 - 105 °C 2: 2.) K2CO3, NaI / 1.) DMF, 3 h, 2.) room temperature, 16 h View Scheme |
The CAS register number of Alizapride is 59338-93-1. It also can be called as N-(1-Allyl-2-pyrrolidinylmethyl)-6-methoxy-1H-benzotriazole-5-carboxamide and the IUPAC name about this chemical is 6-methoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-2H-benzotriazole-5-carboxamide. The molecular formula about this chemical is C16H21N5O2 and molecular weight is 315.37. Classification code about this chemical are Antiemetics, Autonomic Agents, Central Nervous System Agents, Drug / Therapeutic Agent, Gastrointestinal Agents, Human Data and Peripheral Nervous System Agents. This chemical is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.
Physical properties about Alizapride are: (1)ACD/LogP: 0.59; (2)ACD/LogD (pH 5.5): -2.13; (3)ACD/LogD (pH 7.4): -0.9; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 1.62; (8)#H bond acceptors: 7; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 6; (11)Polar Surface Area: 63.49Å2; (12)Index of Refraction: 1.604; (13)Molar Refractivity: 88.72 cm3; (14)Molar Volume: 257.6 cm3; (15)Polarizability: 35.17x10-24cm3; (16)Surface Tension: 53.7 dyne/cm; (17)Enthalpy of Vaporization: 86.81 kJ/mol; (18)Boiling Point: 580.3 °C at 760 mmHg; (19)Vapour Pressure: 1.84E-13 mmHg at 25°C.
Uses of N-(1-Allyl-2-pyrrolidinylmethyl)-6-methoxy-1H-benzotriazole-5-carboxamide: it can be used to produce N-[(1-allyl-2-pyrrolidinyl)methyl]-6-hydroxy-1H-benzotriazole-5-carboxamide at temperature of 100 - 105 ℃. This reaction will need reagent sodium hydride, ethanethiol and solvent dimethylformamide with reaction time of 90 min. The yield is about 46%.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C(c2cc1nnnc1cc2OC)NCC3N(C\C=C)CCC3
(2)InChI: InChI=1/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20)
(3)InChIKey: KSEYRUGYKHXGFW-UHFFFAOYAP
(4)Std. InChI: InChI=1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20)
(5)Std. InChIKey: KSEYRUGYKHXGFW-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
human | TDLo | intravenous | 14mg/kg/10H-I (14mg/kg) | BEHAVIORAL: HEADACHE VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION | New England Journal of Medicine. Vol. 312, Pg. 1125, 1985. |